| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/20/2006 | WO2006041173A1 Enteric nutritional supplement |
| 04/20/2006 | WO2006040980A1 Lecithinized superoxide dismutase composition and process for producing the same |
| 04/20/2006 | WO2006040196A1 4-hydroxy tamoxifen gel formulations |
| 04/20/2006 | WO2006040129A2 Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
| 04/20/2006 | WO2006040047A2 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 04/20/2006 | WO2005120588A3 Peptides delivered to cell nuclei |
| 04/20/2006 | WO2005112984A3 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 04/20/2006 | WO2005110361A3 Nucleotide-cochleate compositions and methods of use |
| 04/20/2006 | WO2005107811A3 Drug delivery device |
| 04/20/2006 | WO2005094893A3 Freeze-dried, free-flowing, particulate composition having improved palatability |
| 04/20/2006 | WO2005074993A3 Method for producing conjugates of polysaccharides and polynucleotides |
| 04/20/2006 | WO2005074912A3 Antiparasitic composition containing an organic amine salt of closantel |
| 04/20/2006 | WO2005063218A3 Pharmaceutical formulations of bisphosphonates |
| 04/20/2006 | WO2004071420A3 Compositions and methods for less immunogenic protein formulations |
| 04/20/2006 | WO2004044011A3 Combinatorial libraries of monomer domains |
| 04/20/2006 | US20060084797 High affinity TGFbeta nucleic acid ligands and inhibitors |
| 04/20/2006 | US20060084793 G-CSF polypeptides and conjugates |
| 04/20/2006 | US20060084759 Obtained by reacting phenolic alcohols with polyamines or polycarboxylates to form networks useful in artificial tissue and tissue engineering, such as artificial or synthetic cartilage, implantable |
| 04/20/2006 | US20060084728 Polymer composites containing keratin |
| 04/20/2006 | US20060084685 Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 04/20/2006 | US20060084684 Topically applicable pharmaceutical preparation |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060084633 Formulations for treating or preventing mucositis |
| 04/20/2006 | US20060084617 Methods for delivery of nucleic acids |
| 04/20/2006 | US20060084610 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 04/20/2006 | US20060084595 Complex comprising OCIF and polysaccharide |
| 04/20/2006 | US20060084593 Anti-hiv composition, production method thereof and medicament |
| 04/20/2006 | US20060084149 Forming complex in which single-stranded nucleic acid is bound to a double-stranded beta -1,3-glucan which as 1,6-glucopyranoside branch and is chemically modified through periodate oxidation and reductive amination so as to impart nucleic acid-binding functional groups; for use as an antisense agent |
| 04/20/2006 | US20060084124 Localization of A2B AdoR on human normal and diseased tissue: the use of anti-A2B antibody to diagnose and treat human tumors |
| 04/20/2006 | US20060083792 Utilizing nanocrystalline silver metal, alloy or compound for localized tissue infections; reducing side effects; limiting overuse of antibiotics |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083782 Methods and compositions useful for administration of chemotherapeutic agents |
| 04/20/2006 | US20060083780 liposomes; nucleic acid lipid particles; gene therapy; improved membrane fluidity |
| 04/20/2006 | US20060083778 Controlled release compositions of estradiol metabolites |
| 04/20/2006 | US20060083777 Providing localized antimicrobial and antiinflammatory effect; utilizing crystalline silver metal, alloy or compound |
| 04/20/2006 | US20060083748 Calixarenes for use as excipient for an active substance |
| 04/20/2006 | US20060083745 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 04/20/2006 | US20060083739 Treating prostate cancer with anti-ErbB2 antibodies |
| 04/20/2006 | US20060083733 High-concentration preparation of soluble thrombomodulin |
| 04/20/2006 | US20060083716 Composition for delivering an agent to a target cell and uses thereof |
| 04/20/2006 | US20060083711 Methods and products related to the intracellular delivery of polysaccharides |
| 04/20/2006 | US20060083700 Use of a novel phytonutrient rich bioactive concentrate (Ri-ActiveTM) for the prevention and treatment of cardiovascular disease, diabetes and other health disorders |
| 04/20/2006 | US20060083693 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 04/20/2006 | US20060083692 Combination of formoterol and a tiotropium salt |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | DE102004049574A1 Arzneimittel und System zur perkutanen Arzneistoffverabreichung Drugs and system for percutaneous drug administration |
| 04/20/2006 | DE10127897B4 Manteltablette mit Pflanzentrockenextrakten Coated tablet with dry plant extracts |
| 04/20/2006 | CA2624601A1 Relevance of achieved levels of markers of systemic inflammation following treatment |
| 04/20/2006 | CA2583341A1 Method of formation of the shape-retentive aggregates of gel particles and their uses |
| 04/20/2006 | CA2583137A1 Therapeutic agents with decreased toxicity |
| 04/20/2006 | CA2582589A1 Lipopolymer conjugates |
| 04/20/2006 | CA2581605A1 Enteral nutrient |
| 04/20/2006 | CA2577535A1 Resorbable ceramic compositions |
| 04/19/2006 | EP1647494A2 Injection moulded water-soluble container |
| 04/19/2006 | EP1647282A1 Topical anti-inflammatory aqueous gel containing menthol, thymol and eucalyptol, process for their preparation and use of thereof |
| 04/19/2006 | EP1647277A1 Glycoside-containing liposome |
| 04/19/2006 | EP1647273A1 Ophthalmic composition |
| 04/19/2006 | EP1647271A1 4-Hydroxy tamoxifen gel formulations |
| 04/19/2006 | EP1647269A1 Matrix adjuvants and the drop pills prepared with them |
| 04/19/2006 | EP1646684A2 Polymer encapsulation of adenoviruses |
| 04/19/2006 | EP1646405A1 Pharmaceutical compositions comprising peranhydrocyclodextrin |
| 04/19/2006 | EP1646401A2 Specific human antibodies |
| 04/19/2006 | EP1646393A1 A stable clozapine suspension formulation |
| 04/19/2006 | EP1646370A1 Pharmaceutical formulations |
| 04/19/2006 | EP1646366A1 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process |
| 04/19/2006 | EP1646364A1 Hfc solution formulations containing an anticholinergic |
| 04/19/2006 | EP1646357A2 Pro104 antibody compositions and methods of use |
| 04/19/2006 | EP1646352A2 Cell permeable conjugates of peptides for inhibition of protein kinases |
| 04/19/2006 | EP1646282A1 Genetic vaccines for cancer therapy |
| 04/19/2006 | EP1562573B1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
| 04/19/2006 | EP1531846A4 Conjugates of ligand, linker and cytotoxic agent and related compositions and methods of use |
| 04/19/2006 | EP1492569A4 Aqueous dispersible steryl ester compositions |
| 04/19/2006 | EP1392485B1 Method for injection moulding moulded bodies consisting of (meth)acrylate copolymers |
| 04/19/2006 | EP1368016B1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt |
| 04/19/2006 | EP1301175B1 Suppository and composition comprising at least one polyethylene glycol |
| 04/19/2006 | EP1276495B1 Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases |
| 04/19/2006 | EP1239857B1 Dual-release compositions of a cyclooxygenase-2- inhibitor |
| 04/19/2006 | EP1239849B1 Pharmaceutical formulations comprising resveratrol and use thereof |
| 04/19/2006 | EP1235560B1 Microchip devices for delivery of molecules and methods of fabrication thereof |
| 04/19/2006 | EP1228199B1 Method for directed packaging of molecular substances in protein shells |
| 04/19/2006 | EP1227820B1 Oligosaccharide aldonic acids and their topical use |
| 04/19/2006 | EP1143940B1 Compositions and methods for mucosal delivery |
| 04/19/2006 | EP1143806B1 Method for increasing pet activity |
| 04/19/2006 | EP1107772B1 Composition with bacillus coagulans and use thereof |
| 04/19/2006 | EP1100820B1 Pectic substance as a growth factor stabilizer |
| 04/19/2006 | EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants |
| 04/19/2006 | EP1001748B1 A process for the preparation of a granulate suitable to the preparation of rapidly disintegrable mouth-soluble tablets |
| 04/19/2006 | EP0946143B1 A nitroimidazole gel composition |
| 04/19/2006 | CN1761684A Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 04/19/2006 | CN1761665A Antitumor effect potentiator and antitumor agent |
| 04/19/2006 | CN1761661A Pharmaceutical preparations containing arginine amides |
| 04/19/2006 | CN1761487A Dispersible formulation of an anti-inflammatory agent |
| 04/19/2006 | CN1761486A Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 04/19/2006 | CN1761485A Micellar preparation containing sparingly water-soluble anticancer agent and novel block copolymer |
| 04/19/2006 | CN1761482A Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 04/19/2006 | CN1761477A Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 04/19/2006 | CN1761473A Heterobifunctional polymeric bioconjugates |
| 04/19/2006 | CN1761469A Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 04/19/2006 | CN1761462A Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 04/19/2006 | CN1761461A Compositions and methods for treatment of premature ejaculation |